Demo

2007 Articles Matching "price"

How Reselling Unused Test Strips For Blood Glucose Is Driving An Unusual Trade Online And On The Streets

Jan 16, 2019 , Kaiser Health News
Often the sellers of the strips are insured and paid little out of pocket for them, while the buyers may be underinsured or uninsured, and unable to pay retail prices, which can run well over $100 for a box of 100 strips. Unlike the resale of prescription drugs, which is prohibited by law, it is generally legal to resell unused test...
Read more

Azar says drug price model has already changed the market

Jan 16, 2019 , Modern Healthcare Breaking News
HHS Secretary Alex Azar said a proposal to tie prices for certain Medicare drugs to lower prices paid overseas is already paying dividends even though it hasn't formally been introduced...
Read more

House Dems Open Investigation Into Pharma’s Drug Pricing Strategies, Calling The Probe One Of The Broadest In Decades

Jan 16, 2019 , Kaiser Health News
House Oversight and Reform Committee Chairman Elijah Cummings sent letters to drugmakers requesting detailed information about their pricing practices, focusing on drugs that are the costliest to Medicare Part D as well as drugs that have had the largest increases over a five-year period. The move is just the latest in a flurry of legislation and congressional action taken on the topic of high drug prices this year....
Read more

‘Fanciful, Inflated, Difficult To Decode And Inconsistent’: Experts Blast Rules Requiring Hospitals To Post Prices

Jan 15, 2019 , Kaiser Health News
The Trump administration now requires hospitals to post their chargemasters online in an effort to increase pricing transparency in the industry. But many experts criticize the rules, saying the information is unusable to consumers. In other hospital news: children's hospitals brace for changes from the administration's tax reform law, and hospitals push physicians to go in-network....
Read more

U.S. lawmaker launches investigation into pharma drug pricing

Jan 15, 2019 , Reuters
A top U.S. lawmaker launched an investigation into pharmaceutical industry pricing practices on Monday, less than a week after he and fellow Democrats introduced legislation aimed at lowering medicine prices....
Read more
Cardon Children's Medical Center

J.P. Morgan Healthcare Conference brings out the high prices

Jan 14, 2019 , Modern Healthcare Breaking News
As 9,000-plus executives descended on San Francisco last week for the annual festival of finance known as the J.P. Morgan Healthcare Conference, things got a little intense, with steep prices all...
Read more

2019 will reveal more answers on Trump's strategy to fight high drug prices

Jan 13, 2019 , Modern Healthcare Breaking News
The Trump administration continues its verbal assault on high drug prices, and more-concrete regulatory action is expected this...
Read more

CMS Chief Acknowledges Flaws In Hospital Price Transparency Requirements But Says They’re An ‘Important First Step’

Jan 12, 2019 , Kaiser Health News
Since Jan. 1, hospitals must post a list of their standard charges in a machine-readable format on their website and update the information at least once a year, but many experts have said that those numbers are meaningless to consumers....
Read more

Even Older Drugs Are Getting Steep Price Hikes, Study Finds

Jan 11, 2019 , MedicineNet
Title: Even Older Drugs Are Getting Steep Price Hikes, Study FindsCategory: Health NewsCreated: 1/8/2019 12:00:00 AMLast Editorial Review: 1/9/2019 12:00:00...
Read more

Verma: Chargemaster rule is 'first step' to price transparency

Jan 11, 2019 , Modern Healthcare Breaking News
The CMS is working to improve a new rule requiring hospitals to post chargemaster prices on their websites after experts said the data wouldn't help consumers, Administrator Seema Verma said...
Read more

Novartis migraine drug not cost effective - UK price watchdog

Jan 11, 2019 , Reuters
Britain's drug price watchdog on Thursday rejected Novartis's migraine drug Aimovig for now, concluding in a draft decision that the medicine was not a cost-effective use of National Health Service resources....
Read more
Demo

Sen. Bernie Sanders says 'we will end' Big Pharma 'greed' in legislative push to cut drug prices

Jan 11, 2019 , CNBC Health
The bills, led by Sanders and Reps. Elijah Cummings and Ro Khanna, would permit Health and Human Services Secretary Alex Azar to negotiate lower prices for drugs under Medicare Part D, the federal program for prescription drug...
Read more

Liberal lawmakers challenge Trump with drug cost legislation

Jan 11, 2019 , Modern Healthcare Breaking News
Challenging the Trump administration on a high-profile consumer issue, leading congressional liberals plan to unveil a package of bills Thursday designed to radically reduce what Americans pay for prescription drugs by linking prices to lower...
Read more

Congress revives flurry of drug pricing legislation

Jan 11, 2019 , Modern Healthcare Breaking News
The House Oversight Committee set a hearing on high drug prices for the end of January, and lawmakers this week rushed into the drug pricing debate. But the jury's still out on how aggressive Congress will...
Read more

Sen. Sanders, Rep. Cummings introduce bill to lower U.S. drug prices

Jan 11, 2019 , Reuters
U.S. Senator Bernie Sanders and Representative Elijah Cummings introduced legislation on Thursday aimed at lowering the cost of prescription drugs for American consumers, critiquing President Donald Trump administration's efforts to curb medicine prices....
Read more

J&J raises U.S. prices on around two dozen drugs

Jan 11, 2019 , Reuters
Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products....
Read more

Johnson & Johnson CEO Warns That Pharma Should Police Itself Over Drug Prices As Other Options Could Be ‘Onerous’

Jan 11, 2019 , Kaiser Health News
“If we don’t do this as an industry, I think there will be other alternatives that will be more onerous for us,” Johnson & Johnson CEO Alex Gorsky said at the J.P. Morgan Healthcare Conference in California. Drug pricing was just one of the many topics that were being hotly discussed at the annual event that draws the movers-and-shakers in the...
Read more

‘I Left The Pharmacy And Sat In My Car And Cried’: Soaring Insulin Prices Force Patients To Go Without Or Ration Drugs

Jan 10, 2019 , Kaiser Health News
News outlets report on stories related to pharmaceutical...
Read more

Rite Aid CEO: We're Growing And Relevant

Jan 10, 2019 , Forbes
Despite a stock price trading below $1 per share, Rite Aid CEO John Standley said the drugstore chain remains "very relevant in the markets that we are...
Read more

Perspectives: Should We Actually Expect Congress To Tackle Drug Prices? Remain Skeptical, But Optimistic For Change

Jan 10, 2019 , Kaiser Health News
News outlets report on stories related to pharmaceutical...
Read more